Interest Expense in USD of Emmaus Life Sciences, Inc. from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Emmaus Life Sciences, Inc. quarterly/annual Interest Expense history and change rate from Q2 2018 to Q3 2025.
  • Emmaus Life Sciences, Inc. Interest Expense for the quarter ending 30 Sep 2025 was $1.93M, a 44.3% increase year-over-year.
  • Emmaus Life Sciences, Inc. Interest Expense for the twelve months ending 30 Sep 2025 was $6.14M, a 3.91% decline year-over-year.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2024 was $5.49M, a 25.6% decline from 2023.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2023 was $7.38M, a 47.3% increase from 2022.
  • Emmaus Life Sciences, Inc. annual Interest Expense for 2022 was $5.01M, a 61.7% increase from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

Emmaus Life Sciences, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $6.14M $1.93M +$593K +44.3% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 $5.55M $1.68M +$712K +73.7% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $4.84M $1.26M -$654K -34.2% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $5.49M $1.28M -$901K -41.3% 01 Oct 2024 31 Dec 2024 10-K 14 Apr 2025
Q3 2024 $6.39M $1.34M -$571K -29.9% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 $6.96M $966K -$827K -46.1% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 $7.79M $1.91M +$408K +27.2% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $7.38M $2.18M +$710K +48.3% 01 Oct 2023 31 Dec 2023 10-K 14 Apr 2025
Q3 2023 $6.67M $1.91M +$389K +25.6% 01 Jul 2023 30 Sep 2023 10-Q 19 Nov 2024
Q2 2023 $6.28M $1.79M +$506K +39.3% 01 Apr 2023 30 Jun 2023 10-Q 10 Sep 2024
Q1 2023 $5.78M $1.5M +$765K +104% 01 Jan 2023 31 Mar 2023 10-Q 10 Sep 2024
Q4 2022 $5.01M $1.47M +$758K +107% 01 Oct 2022 31 Dec 2022 10-K 03 Jul 2024
Q3 2022 $4.26M $1.52M +$837K +123% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 $3.42M $1.29M +$634K +97.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $2.78M $737K -$317K -30.1% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $3.1M $711K -$563K -44.2% 01 Oct 2021 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $3.66M $683K -$923K -57.5% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 $4.59M $653K -$656K -50.1% 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022
Q1 2021 $5.24M $1.05M -$746K -41.4% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q4 2020 $5.99M $1.27M -$1.2M -48.5% 01 Oct 2020 31 Dec 2020 10-K 31 Mar 2022
Q3 2020 $7.19M $1.61M -$7.11M -81.6% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $14.3M $1.31M -$6.52M -83.3% 01 Apr 2020 30 Jun 2020 10-Q 01 Sep 2021
Q1 2020 $20.8M $1.8M -$6.81M -79.1% 01 Jan 2020 31 Mar 2020 10-Q 01 Sep 2021
Q4 2019 $27.6M $2.47M 01 Oct 2019 31 Dec 2019 10-K/A 10 Aug 2021
Q3 2019 $8.71M +$3.19M +57.7% 01 Jul 2019 30 Sep 2019 10-Q 26 Aug 2021
Q2 2019 $7.83M +$2.38M +43.7% 01 Apr 2019 30 Jun 2019 10-Q 26 Aug 2021
Q1 2019 $8.61M 01 Jan 2019 31 Mar 2019 10-Q 26 Aug 2021
Q3 2018 $5.53M 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 $5.45M 01 Apr 2018 30 Jun 2018 8-K/A 14 Aug 2019

Emmaus Life Sciences, Inc. Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.49M -$1.89M -25.6% 01 Jan 2024 31 Dec 2024 10-K 14 Apr 2025
2023 $7.38M +$2.37M +47.3% 01 Jan 2023 31 Dec 2023 10-K 14 Apr 2025
2022 $5.01M +$1.91M +61.7% 01 Jan 2022 31 Dec 2022 10-K 03 Jul 2024
2021 $3.1M -$2.89M -48.2% 01 Jan 2021 31 Dec 2021 10-K 31 Mar 2023
2020 $5.99M -$21.6M -78.3% 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2019 $27.6M +$4.83M +21.2% 01 Jan 2019 31 Dec 2019 10-K/A 10 Aug 2021
2018 $22.8M 01 Jan 2018 31 Dec 2018 10-K 25 Jan 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.